{"id":"W2035320881","doi":"10.1002/art.37816","title":"Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study","year":2013,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":582,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Placebo; Rheumatoid arthritis; Internal medicine; Interim analysis; Janus kinase inhibitor; Rheumatology; Methotrexate; Randomized controlled trial; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041516,0.0009097319,0.001953801,0.0003461467,0.0004981832,0.0007668542,0.0007370819,0.00110847,0.00276985],"category_scores_gemma":[0.001896683,0.0004382529,0.001418988,0.0004348197,0.0006052266,0.0006030299,0.0002916477,0.001757087,0.0007382125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003948589,"about_ca_system_score_gemma":0.000945875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005199763,"about_ca_topic_score_gemma":0.00124669,"domain_scores_codex":[0.9989084,0.000591204,0.0001066413,0.00010959,0.0001575256,0.0001265184],"domain_scores_gemma":[0.9981048,0.0004047223,0.0005838409,0.0001895519,0.0001802074,0.0005367398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8117293,0.03062144,0.01542258,0.00129661,0.002908217,0.0002808048,0.0002009831,0.0008753712,0.035033,0.00007254494,0.002887029,0.0986722],"study_design_scores_gemma":[0.5614201,0.3712254,0.05841985,0.00007646147,0.001788604,0.000407046,0.00004410601,0.0005363139,0.003095987,0.00006442553,0.002876508,0.00004519732],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866617,0.007199382,0.0009725476,0.0003492965,0.00009587067,0.001963024,0.001286728,0.0001034735,0.001368044],"genre_scores_gemma":[0.9877936,0.003658196,0.001849544,0.0007555117,0.0002971776,0.001750802,0.002478233,0.00002150193,0.001395422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0041516,"threshold_uncertainty_score":0.02195603,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01977718972046093,"score_gpt":0.2746561175317261,"score_spread":0.2548789278112652,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}